Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese
Clinical trial NCT03995550 · WITHDRAWN
Trial details
- NCT number
- NCT03995550
- Sponsor
- LEO Pharma
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2020-01-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.